Insception Biosciences

About:

Insception Biosciences is a cord blood program in Canada.

Website: https://www.insception.com/

Twitter/X: insception

Top Investors: MMV Capital Partners, Wellington Financial

Description:

Insception is the largest cord blood program in Canada with over 39,000 cord blood units banked. Insception is owned by Argosy Partners, Mount Sinai Hospital, management and its scientific founders. By partnering with leading Canadian medical facilities such as Toronto's Mount Sinai and the Scarborough Hospitals, Insception continues to work closely with Canada's leading healthcare providers. The Insception Cord Blood Program is able to provide every Canadian family with security, state of the art processing and storage, financial stability and long term professional governance.

Total Funding Amount:

$7.25M

Headquarters Location:

Mississauga, Ontario, Canada

Founded Date:

1996-01-01

Contact Email:

info(AT)insception.com

Founders:

Ian Rogers, Robert Casper

Number of Employees:

51-100

Last Funding Date:

2012-09-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai